
Patient-reported outcomes in relapsed ovarian cancer: Results from a randomized Phase III study of trabectedin with pegylated liposomal doxorubicin (PLD) versus PLD Alone ★
Keywords: سرطان تخمدان ریفلاکس; Trabectedin; Yondelis®; Pegylated liposomal doxorubicin; DOXIL®; Relapsed ovarian cancer; Patient-reported outcome